NUVARING

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NUVARING contains a combination of these active pharmaceutical ingredients (APIs):

1 Etonogestrel
UNII 304GTH6RNH - ETONOGESTREL

Etonogestrel is the biologically active metabolite of desogestrel, a progestagen widely used in OCs. It is structurally derived from 19-nortestosterone and binds with high affinity to progesterone receptors in the target organs. The contraceptive effect of etonogestrel is primarily achieved by inhibition of ovulation.

Read about Etonogestrel
2 17 alpha-Ethinylestradiol
UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

Read about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G02BB01 Vaginal ring with progestogen and estrogen G Genito urinary system and sex hormones → G02 Other gynecologicals → G02B Contraceptives for topical use → G02BB Intravaginal contraceptives
Discover more medicines within G02BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 527302401176313, 527319060019403, 527319060019503
Country: CA Health Products and Food Branch Identifier(s): 02253186
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 25.317-08-03
Country: EE Ravimiamet Identifier(s): 1138621, 1138632
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 5717756, 64570
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 005369, 005436
Country: FR Base de données publique des médicaments Identifier(s): 62148867
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 153646, 374065, 381569
Country: IE Health Products Regulatory Authority Identifier(s): 36003
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4937
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1015653, 1015654, 1058012, 1083147, 1083148, 1093332
Country: MT Medicines Authority Identifier(s): MA031/02201
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 422M2003
Country: NL Z-Index G-Standaard, PRK Identifier(s): 72885
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100180329, 100429496, 100446508, 100447123
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68335001, W68335002, W68335003, W68335004
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8683280337305
Country: US FDA, National Drug Code Identifier(s): 0052-0273, 50090-1008
Country: ZA Health Products Regulatory Authority Identifier(s): 38/34/0171

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.